Roche/Genentech Inc. is using “smart development” strategies to manage the increasing complexity of oncology development by allowing the company to “learn on the go” – rapidly and efficiently moving clinical development forward using biomarkers and parallel clinical trial designs that continue to feed information back to the company, which can then modify other studies in response.
Roche Oncology Trials Designed For “Learning On The Go”
Roche is innovating in the structure of clinical development to manage the increasingly complex knowledge of cancer biology, using adaptive trial designs and extensive analysis of responders to find biomarkers that can inform, adjust and enrich clinical studies in a continually iterative process of “learning on the go.”